West Hollywood, California Clinical Trials

A listing of West Hollywood, California clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 80 clinical trials
Treatment of Moderate to Severe Lateral Canthal Lines and Glabellar Lines Alone or in Combination

This study is designed to evaluate the safety and efficacy of a single dose of QM1114-DP for the treatment of moderate to severe LCL and moderate to severe GL, alone or in combination.

Skin Care & Laser Physicians of Beverly Hills
 (1.0 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +9 other locations
Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body

This phase III trial studies how well the addition of radiotherapy to the usual treatment (chemotherapy) works compared to the usual treatment alone in treating patients with esophageal and gastric cancer that has spread to a limited number of other places in the body (oligometastatic disease). Radiotherapy uses high energy …

folfox regimen
celiac disease
esophageal cancer
solid tumor
absolute neutrophil count
Providence Saint Joseph Medical Center/Disney Family Cancer Center
 (5.1 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +254 other locations
Expanded Access of Omidubicel for Allogeneic Transplantation in Patients With Hematological Malignancies

Omidubicel is an investigational therapy for patients with high-risk hematologic malignancies.

investigational treatment
allogeneic transplantation
cancer
hematologic malignancy
UCLA
 (4.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +3 other locations
Helping Families Pilot of a Family Resilience Program for Families Experiencing Homelessness and Parental Substance Use

The goal of this study is to pilot an adapted family resilience program among families with a recent history of homelessness and parental substance use disorders in Los Angeles County and to assess for feasibility and acceptability. The investigators have adapted a family resilience program called Families Overcoming Under Stress …

UCLA
 (4.9 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • 1 location
Phase 2 Clinical Trial of Crizotinib for Children and Adults With Neurofibromatosis Type 2 and Progressive Vestibular Schwannomas

Subjects with Neurofibromatosis Type 2 (NF2) and progressive vestibular schwannoma (VS) will be treated with crizotinib administered orally. Crizotinib will be taken continuously until disease progression or unacceptable toxicity, in continuous treatment cycles of 28 days each, for a maximum of 12 cycles.

schwartz
glioma
neutrophil count
nf2 gene
crizotinib
Univ of California @ Los Angeles (Site 325)
 (4.5 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +16 other locations
A Study to Evaluate NT219 Alone and in Combination With ERBITUX (Cetuximab) in Adults With Advanced Solid Tumors and Head and Neck Cancer

This is a phase 1/2, multi-center study with an open-label, dose escalation phase followed by a single-arm expansion phase to assess the safety, tolerability, pharmacokinetics, pharmacodynamics, and efficacy of NT219 alone and in combination with ERBITUX (cetuximab) in adults with recurrent and/or metastatic solid tumors.

pd-l1
serum pregnancy test
squamous cell carcinoma of head and neck
solid tumors
brain metastasis
The Angeles Clinic and Research Institute
 (5.8 away) Contact site
  • 0 views
  • 19 Feb, 2024
  • +5 other locations
Dupilumab Asthma Sleep Study

Primary Objective: To assess the effect of dupilumab on sleep Secondary Objectives: To evaluate the effect of dupilumab on additional patient reported sleep outcomes To evaluate the effect of dupilumab on objective sleep assessment To evaluate the effect of dupilumab on asthma symptoms To evaluate the effect of dupilumab on …

polysomnography
forced expiratory volume
leukotriene receptor antagonist
eosinophil count
fractional exhaled nitric oxide
Investigational Site Number 8400009
 (1.2 away) Contact site
  • 0 views
  • 24 Nov, 2025
  • +10 other locations
Study of ATI-2138 in Adult Participants with Moderate to Severe Atopic Dermatitis

This is a Phase 2 open label study of ATI-2138 in participants with moderate to severe atopic dermatitis.

Aclaris Investigational Site
 (8.6 away) Contact site
  • 0 views
  • 23 Jan, 2025
  • +4 other locations
None

Los Angeles Cancer Network
 (5.9 away) Contact site
  • 0 views
  • 19 May, 2025
  • +12 other locations
None

Los Angeles Cancer Network
 (5.9 away) Contact site
  • 0 views
  • 19 May, 2025
  • +13 other locations